Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Murphy

Showing results (391-400 of 431) with videos related to

Pageof 44
Sort By:
Science (New York, N.Y.)|October 10, 2020
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamstersAlina Baum, Dharani Ajithdoss, Richard Copin, et al.
Nature Reviews. Urology|October 17, 2023
Hallmark discoveries in the biology of Wilms tumourDaniela Perotti, Richard D Williams, Jenny Wegert, et al.
Cell Reports|December 8, 2022
Cancer cell-derived type I interferons instruct tumor monocyte polarizationDylan Kwart, Jing He, Subhashini Srivatsan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2013
Conditionals by inversion provide a universal method for the generation of conditional allelesAris N Economides, David Frendewey, Peter Yang, et al.
JCI Insight|June 23, 2025
A TMPRSS6-inhibiting mAb improves disease in a β-thalassemia mouse model and reduces iron in healthy humansHeinrich E Lob, Nikhil Singh, Kusha Mohammadi, et al.
Research Square|March 30, 2023
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q StudyAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications|December 18, 2023
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-QAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.
Nature Communications|September 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticityShivendra Singh, Jie Fang, Hongjian Jin, et al.
Pediatric Blood & Cancer|September 3, 2025
Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma ResectionStephanie F Polites, Jennifer H Aldrink, Timothy B Lautz, et al.
Pageof 44

Showing results (391-400 of 431) with videos related to

Sort By:
Pageof 44
Science (New York, N.Y.)|October 10, 2020
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamstersAlina Baum, Dharani Ajithdoss, Richard Copin, et al.
Nature Reviews. Urology|October 17, 2023
Hallmark discoveries in the biology of Wilms tumourDaniela Perotti, Richard D Williams, Jenny Wegert, et al.
Cell Reports|December 8, 2022
Cancer cell-derived type I interferons instruct tumor monocyte polarizationDylan Kwart, Jing He, Subhashini Srivatsan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2013
Conditionals by inversion provide a universal method for the generation of conditional allelesAris N Economides, David Frendewey, Peter Yang, et al.
JCI Insight|June 23, 2025
A TMPRSS6-inhibiting mAb improves disease in a β-thalassemia mouse model and reduces iron in healthy humansHeinrich E Lob, Nikhil Singh, Kusha Mohammadi, et al.
Research Square|March 30, 2023
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q StudyAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications|December 18, 2023
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-QAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.
Nature Communications|September 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticityShivendra Singh, Jie Fang, Hongjian Jin, et al.
Pediatric Blood & Cancer|September 3, 2025
Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma ResectionStephanie F Polites, Jennifer H Aldrink, Timothy B Lautz, et al.
Pageof 44